These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15104592)

  • 21. Catalytic M1GS RNA as an antiviral agent in animals.
    Bai Y; Rider PJ; Liu F
    Methods Mol Biol; 2010; 629():339-53. PubMed ID: 20387160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on the targeting effects of M1-GS RNA on K562 cells].
    Chen BB; Lin GW; Lu HZ; Fan HH; Gao L
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):552-5. PubMed ID: 15569537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture.
    Kilani AF; Trang P; Jo S; Hsu A; Kim J; Nepomuceno E; Liou K; Liu F
    J Biol Chem; 2000 Apr; 275(14):10611-22. PubMed ID: 10744757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular expression of engineered RNase P ribozymes effectively blocks gene expression and replication of human cytomegalovirus.
    Kim K; Umamoto S; Trang P; Hai R; Liu F
    RNA; 2004 Mar; 10(3):438-47. PubMed ID: 14970389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
    Kronenwett R; Haas R; Sczakiel G
    J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro selection of external guide sequences for directing human RNase P to cleave a target mRNA.
    Raj S; Liu F
    Methods Mol Biol; 2004; 252():413-24. PubMed ID: 15017067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.
    Trang P; Lee M; Nepomuceno E; Kim J; Zhu H; Liu F
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5812-7. PubMed ID: 10811889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNase P of the Cyanophora paradoxa cyanelle: a plastid ribozyme.
    Li D; Willkomm DK; Schön A; Hartmann RK
    Biochimie; 2007 Dec; 89(12):1528-38. PubMed ID: 17881113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth.
    Trang P; Kim K; Zhu J; Liu F
    J Mol Biol; 2003 May; 328(5):1123-35. PubMed ID: 12729746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNase P Ribozymes Inhibit the Replication of Human Cytomegalovirus by Targeting Essential Viral Capsid Proteins.
    Yang Z; Reeves M; Ye J; Trang P; Zhu L; Sheng J; Wang Y; Zen K; Wu J; Liu F
    Viruses; 2015 Jun; 7(7):3345-60. PubMed ID: 26114473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals.
    Li W; Liu Y; Wang Y; Li R; Trang P; Tang W; Yang Z; Wang Y; Sun X; Xing X; Lu S; Liu F
    Theranostics; 2018; 8(20):5634-5644. PubMed ID: 30555569
    [No Abstract]   [Full Text] [Related]  

  • 32. Structure of ribonuclease P--a universal ribozyme.
    Torres-Larios A; Swinger KK; Pan T; Mondragón A
    Curr Opin Struct Biol; 2006 Jun; 16(3):327-35. PubMed ID: 16650980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Construction of an engineered M1GS-HCV/C141 ribozyme and determination of its antiviral activity in vitro].
    Li X; Zhang W; Huang Z; Zhang C; Luo G
    Sheng Wu Gong Cheng Xue Bao; 2013 Dec; 29(12):1786-95. PubMed ID: 24660626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of the protein cofactor on the interactions between an RNase P ribozyme and its target mRNA substrate.
    Hsu AW; Kilani AF; Liou K; Lee J; Liu F
    Nucleic Acids Res; 2000 Aug; 28(16):3105-16. PubMed ID: 10931926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.
    Sullivan JM; Pietras KM; Shin BJ; Misasi JN
    Mol Vis; 2002 Apr; 8():102-13. PubMed ID: 11961505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trans-splicing ribozymes for targeted gene delivery.
    Köhler U; Ayre BG; Goodman HM; Haseloff J
    J Mol Biol; 1999 Feb; 285(5):1935-50. PubMed ID: 9925776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNase P: from biological function to biotechnological applications.
    Cobaleda C; Sánchez-García I
    Trends Biotechnol; 2001 Oct; 19(10):406-11. PubMed ID: 11587766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antisense inhibition of Escherichia coli RNase P RNA: mechanistic aspects.
    Gruegelsiepe H; Willkomm DK; Goudinakis O; Hartmann RK
    Chembiochem; 2003 Oct; 4(10):1049-56. PubMed ID: 14523923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An intron promotes the anti-bcr-abl activities of a retrovirally expressed ribozyme in chronic myeloid leukemia cells.
    Liu JH; Wu SC; Chen WS; Yen CC; Yang MH; Tsai YC; Chen PM
    Biochem Biophys Res Commun; 2004 Jun; 318(3):764-72. PubMed ID: 15144904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction of an effective m1 GS ribozyme targeting HCMV UL97 mRNA segment in vitro.
    Zhang WJ; Li HJ; Li YQ; He HK; Tang DS; Zhang X; Zhou TH
    Yi Chuan Xue Bao; 2005 Nov; 32(11):1205-12. PubMed ID: 16318287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.